131 related articles for article (PubMed ID: 30113113)
1. Assisted reproductive technology is effective for but does not affect the prognosis of young patients with breast cancer: Experience in a single institution.
Takuwa H; Hagiwara R; Takahara S; Yamauchi A
Breast J; 2018 Nov; 24(6):1001-1005. PubMed ID: 30113113
[TBL] [Abstract][Full Text] [Related]
2. Assisted reproductive technology use and outcomes among women with a history of cancer.
Luke B; Brown MB; Missmer SA; Spector LG; Leach RE; Williams M; Koch L; Smith YR; Stern JE; Ball GD; Schymura MJ
Hum Reprod; 2016 Jan; 31(1):183-9. PubMed ID: 26577302
[TBL] [Abstract][Full Text] [Related]
3. Fertility in Women of Reproductive Age After Breast Cancer Treatment: Practice Patterns and Outcomes.
McCray DK; Simpson AB; Flyckt R; Liu Y; O'Rourke C; Crowe JP; Grobmyer SR; Moore HC; Valente SA
Ann Surg Oncol; 2016 Oct; 23(10):3175-81. PubMed ID: 27334218
[TBL] [Abstract][Full Text] [Related]
4. Patient Location and Disparities in Access to Fertility Preservation for Women With Gynecologic or Breast Cancer.
Kanbergs A; Jorgensen K; Agusti N; Viveros-Carreño D; Wu CF; Nitecki R; Harris JA; Woodard T; Ramphul R; Rauh-Hain JA
Obstet Gynecol; 2024 Jun; 143(6):824-834. PubMed ID: 38574368
[TBL] [Abstract][Full Text] [Related]
5. Fertility preservation and breast cancer: A complex problem.
Munster PN
Oncology (Williston Park); 2013 Jun; 27(6):533-9. PubMed ID: 23909066
[TBL] [Abstract][Full Text] [Related]
6. Fertility after breast cancer treatment.
Kasum M; Beketić-Orešković L; Peddi PF; Orešković S; Johnson RH
Eur J Obstet Gynecol Reprod Biol; 2014 Feb; 173():13-8. PubMed ID: 24315568
[TBL] [Abstract][Full Text] [Related]
7. Pregnancy following breast cancer using assisted reproduction and its effect on long-term outcome.
Goldrat O; Kroman N; Peccatori FA; Cordoba O; Pistilli B; Lidegaard O; Demeestere I; Azim HA
Eur J Cancer; 2015 Aug; 51(12):1490-6. PubMed ID: 26070684
[TBL] [Abstract][Full Text] [Related]
8. Survival outcomes following pregnancy or assisted reproductive technologies after breast cancer: A population-based study.
Rauh-Hain JA; Zubizarreta J; Nitecki R; Melamed A; Fu S; Jorgensen K; Brady PC; Baker VL; Chavez-MacGregor M; Giordano SH; Keating NL
Cancer; 2022 Sep; 128(17):3243-3253. PubMed ID: 35767282
[TBL] [Abstract][Full Text] [Related]
9. Gonadotropin-releasing hormone agonists for ovarian protection during cancer chemotherapy: systematic review and meta-analysis.
Senra JC; Roque M; Talim MCT; Reis FM; Tavares RLC
Ultrasound Obstet Gynecol; 2018 Jan; 51(1):77-86. PubMed ID: 29055060
[TBL] [Abstract][Full Text] [Related]
10. Is Menstruation or the Serum Hormone Level a Useful Predictor for Live Birth after Gonadotropin-Releasing Hormone Agonist during Chemotherapy in Young Breast Cancer Patients.
Lee DY; Choi D
Gynecol Obstet Invest; 2017; 82(6):601-606. PubMed ID: 28006769
[TBL] [Abstract][Full Text] [Related]
11. Gonadotropin-Releasing Hormone Agonists for Ovarian Function Preservation in Premenopausal Women Undergoing Chemotherapy for Early-Stage Breast Cancer: A Systematic Review and Meta-analysis.
Munhoz RR; Pereira AA; Sasse AD; Hoff PM; Traina TA; Hudis CA; Marques RJ
JAMA Oncol; 2016 Jan; 2(1):65-73. PubMed ID: 26426573
[TBL] [Abstract][Full Text] [Related]
12. Young Women with Breast Cancer: Fertility Preservation Options and Management of Pregnancy-Associated Breast Cancer.
Shah NM; Scott DM; Kandagatla P; Moravek MB; Cobain EF; Burness ML; Jeruss JS
Ann Surg Oncol; 2019 May; 26(5):1214-1224. PubMed ID: 30680478
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer and fertility: an update.
Ronn R; Holzer H
Curr Opin Support Palliat Care; 2015 Sep; 9(3):285-93. PubMed ID: 26262832
[TBL] [Abstract][Full Text] [Related]
14. Fertility Preservation for the Young Breast Cancer Patient.
Goldfarb SB; Kamer SA; Oppong BA; Eaton A; Patil S; Junqueira MJ; Olcese C; Kelvin JF; Gemignani ML
Ann Surg Oncol; 2016 May; 23(5):1530-6. PubMed ID: 26790670
[TBL] [Abstract][Full Text] [Related]
15. Preservation of gonadal function in women undergoing chemotherapy: a review of the potential role for gonadotropin-releasing hormone agonists.
Hickman LC; Valentine LN; Falcone T
Am J Obstet Gynecol; 2016 Oct; 215(4):415-22. PubMed ID: 27422055
[TBL] [Abstract][Full Text] [Related]
16. [Fertility preservation strategies in young women in case of breast cancer or hematologic malignancy].
Decanter C; Robin G
Gynecol Obstet Fertil; 2013 Oct; 41(10):597-600. PubMed ID: 24094596
[TBL] [Abstract][Full Text] [Related]
17. A survey on fertility management in young women of reproductive age treated with chemotherapy.
Abe A; Kuwahara A; Iwasa T; Nishimura M; Irahara M
Int J Clin Oncol; 2016 Dec; 21(6):1183-1190. PubMed ID: 27402102
[TBL] [Abstract][Full Text] [Related]
18. Pregnancy Outcomes After a Breast Cancer Diagnosis: A Systematic Review and Meta-analysis.
Gerstl B; Sullivan E; Ives A; Saunders C; Wand H; Anazodo A
Clin Breast Cancer; 2018 Feb; 18(1):e79-e88. PubMed ID: 28797766
[TBL] [Abstract][Full Text] [Related]
19. Ovarian Function Suppression in Premenopausal Women with Early-Stage Breast Cancer.
Lambertini M; Del Mastro L; Viglietti G; Pondé NF; Solinas C; de Azambuja E
Curr Treat Options Oncol; 2017 Jan; 18(1):4. PubMed ID: 28185173
[TBL] [Abstract][Full Text] [Related]
20. Assisted reproductive technology surveillance--United States, 2000.
Wright VC; Schieve LA; Reynolds MA; Jeng G
MMWR Surveill Summ; 2003 Aug; 52(9):1-16. PubMed ID: 14532867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
